The equity security for Galectin Therapeutics, traded under the ticker symbol GALT on the Nasdaq capital market, changes hands around $3.68 per share. Real-time market tracking tools show typical intraday price variations driven by trading liquidity, volume shifts, and investor sentiment surrounding upcoming clinical milestones and corporate updates.